Ikena Oncology Inc

NASDAQ:IKNA 4:00:00 PM EDT

1.31

-0.01 (-0.76%)

5:10:23 PM EDT: $1.37 +0.06 (+4.58%)

Ikena Oncology Inc Stock, NASDAQ:IKNA

645 Summer Street, Suite 101, Boston, Massachusetts 02210

United States of America

Phone: +1.857.273.8343

Number of Employees: 10

http://www.ikenaoncology.com

Description

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.